Literature DB >> 19598007

Comparison of composite whole body insulin sensitivity index derived from mixed meal test and oral glucose tolerance test in insulin resistant obese subjects.

Hadi Selimoglu1, Cevdet Duran, Sinem Kiyici, Metin Guclu, Canan Ersoy, Guven Ozkaya, Erdinc Erturk, Ercan Tuncel, Sazi Imamoglu.   

Abstract

Apart from fasting blood glucose (FBG) and insulin (FBI), oral glucose tolerance test (OGTT) is also used in calculating insulin sensitivity. During OGTT, insulin secretion may not reflect normal physiological insulin secretion. Based on this idea, hepatic and whole body insulin sensitivity rates were tested during OGTT and mixed meal test (MMT) in obese subjects. Thirty-one women with Quantitative Insulin Sensitivity Check Index (QUICKI) values below 0.350 and body mass index (BMI) >or=30 were included into the study. OGTT with 75-g glucose and MMT 300 kcal were applied to all cases. Data obtained from OGTT and MMT were used in the assessment of insulin sensitivity with Hemostasis of Model Assessment-Insulin Resistance (HOMA-IR) and Matsuda's Composite Whole Body Insulin Sensitivity Index (Matsuda's ISI). Mean BMI, FBG, and FBI were 36.8 +/- 3.9 kg/m(2), 100.5 +/- 0.10 mg/dl, 16.2 +/- 5.3 microg/ml, respectively. QUICKI was 0.31 +/- 0.01 and HOMA-IR was 3.71 +/- 0.88. Matsuda's ISI derived from OGTT was 6.96 +/- 3.35 and from MMT was 11.32 +/- 6.61. In analysis, it was demonstrated that there was a correlation between HOMA-IR, QUICKI, and Matsuda's ISIs derived from OGTT and MMT. Comparing the time periods separately, it was detected that despite similar increment in insulin levels, glucose levels were higher in OGTT than MMT at 15 and 30 min. Consequently, Matsuda's ISI was demonstrated to be effectively used with the data of MMT, as used with OGTT. Moreover, MMT was shown to be in parallel to physiologic insulin secretion and reflect pancreatic functions better compared to OGTT.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19598007     DOI: 10.1007/s12020-009-9213-z

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  23 in total

1.  Use of the oral glucose tolerance test to assess insulin release and insulin sensitivity.

Authors:  M Stumvoll; A Mitrakou; W Pimenta; T Jenssen; H Yki-Järvinen; T Van Haeften; W Renn; J Gerich
Journal:  Diabetes Care       Date:  2000-03       Impact factor: 19.112

Review 2.  The OGTT as test for beta cell function?

Authors:  M Stumvoll; A Fritsche; H Häring
Journal:  Eur J Clin Invest       Date:  2001-05       Impact factor: 4.686

3.  Minimal model estimation of glucose absorption and insulin sensitivity from oral test: validation with a tracer method.

Authors:  Chiara Dalla Man; Andrea Caumo; Rita Basu; Robert Rizza; Gianna Toffolo; Claudio Cobelli
Journal:  Am J Physiol Endocrinol Metab       Date:  2004-05-11       Impact factor: 4.310

Review 4.  Glycaemic effects of incretins in Type 1 diabetes mellitus: a concise review, with emphasis on studies in humans.

Authors:  John Dupre
Journal:  Regul Pept       Date:  2005-06-15

5.  Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp.

Authors:  M Matsuda; R A DeFronzo
Journal:  Diabetes Care       Date:  1999-09       Impact factor: 19.112

6.  Metabolic responses in a model of insulin resistance: comparison between oral glucose and meal tolerance tests.

Authors:  Nathalie Berthiaume; Bradley A Zinker
Journal:  Metabolism       Date:  2002-05       Impact factor: 8.694

7.  Comparison of the metabolic effects of mixed meal and standard oral glucose tolerance test on glucose, insulin and C-peptide response in healthy, impaired glucose tolerance, mild and severe non-insulin-dependent diabetic subjects.

Authors:  S Marena; G Montegrosso; F De Michieli; E Pisu; G Pagano
Journal:  Acta Diabetol       Date:  1992       Impact factor: 4.280

8.  Role of free fatty acids and insulin in determining free fatty acid and lipid oxidation in man.

Authors:  L C Groop; R C Bonadonna; M Shank; A S Petrides; R A DeFronzo
Journal:  J Clin Invest       Date:  1991-01       Impact factor: 14.808

9.  Preservation of pancreatic beta-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk hispanic women.

Authors:  Thomas A Buchanan; Anny H Xiang; Ruth K Peters; Siri L Kjos; Aura Marroquin; Jose Goico; Cesar Ochoa; Sylvia Tan; Kathleen Berkowitz; Howard N Hodis; Stanley P Azen
Journal:  Diabetes       Date:  2002-09       Impact factor: 9.461

Review 10.  New insights into amino acid metabolism, beta-cell function and diabetes.

Authors:  Philip Newsholme; Lorraine Brennan; Blanca Rubi; Pierre Maechler
Journal:  Clin Sci (Lond)       Date:  2005-03       Impact factor: 6.124

View more
  11 in total

1.  Standardized Mixed-Meal Tolerance and Arginine Stimulation Tests Provide Reproducible and Complementary Measures of β-Cell Function: Results From the Foundation for the National Institutes of Health Biomarkers Consortium Investigative Series.

Authors:  Sudha S Shankar; Adrian Vella; Ralph H Raymond; Myrlene A Staten; Roberto A Calle; Richard N Bergman; Charlie Cao; Danny Chen; Claudio Cobelli; Chiara Dalla Man; Mark Deeg; Jennifer Q Dong; Douglas S Lee; David Polidori; R Paul Robertson; Hartmut Ruetten; Darko Stefanovski; Maria T Vassileva; Gordon C Weir; David A Fryburg
Journal:  Diabetes Care       Date:  2016-07-12       Impact factor: 19.112

2.  Plasma total oxidant and antioxidant status after oral glucose tolerance and mixed meal tests in patients with polycystic ovary syndrome.

Authors:  Zehra Kucukaydın; Cevdet Duran; Mustafa Basaran; Fatos Camlica; Sami Said Erdem; Ahmet Basaran; Orkide Kutlu; Ferda Sevimli Burnik; Halis Elmas; Mustafa Sait Gonen
Journal:  J Endocrinol Invest       Date:  2016-06-14       Impact factor: 4.256

3.  Inhibition of IKKɛ and TBK1 Improves Glucose Control in a Subset of Patients with Type 2 Diabetes.

Authors:  Elif A Oral; Shannon M Reilly; Andrew V Gomez; Rasimcan Meral; Laura Butz; Nevin Ajluni; Thomas L Chenevert; Evgenia Korytnaya; Adam H Neidert; Rita Hench; Diana Rus; Jeffrey F Horowitz; BreAnne Poirier; Peng Zhao; Kim Lehmann; Mohit Jain; Ruth Yu; Christopher Liddle; Maryam Ahmadian; Michael Downes; Ronald M Evans; Alan R Saltiel
Journal:  Cell Metab       Date:  2017-07-05       Impact factor: 27.287

4.  Assessing Insulin Sensitivity and Postprandial Triglyceridemic Response Phenotypes With a Mixed Macronutrient Tolerance Test.

Authors:  John W Newman; Sridevi Krishnan; Kamil Borkowski; Sean H Adams; Charles B Stephensen; Nancy L Keim
Journal:  Front Nutr       Date:  2022-05-11

Review 5.  Effects of bariatric surgery on glucose homeostasis and type 2 diabetes.

Authors:  David Bradley; Faidon Magkos; Samuel Klein
Journal:  Gastroenterology       Date:  2012-08-08       Impact factor: 22.682

6.  Rapid development of systemic insulin resistance with overeating is not accompanied by robust changes in skeletal muscle glucose and lipid metabolism.

Authors:  Andrea S Cornford; Alexander Hinko; Rachael K Nelson; Ariel L Barkan; Jeffrey F Horowitz
Journal:  Appl Physiol Nutr Metab       Date:  2012-11-21       Impact factor: 2.665

7.  Postprandial metabolite profiles reveal differential nutrient handling after bariatric surgery compared with matched caloric restriction.

Authors:  Chin Meng Khoo; Michael J Muehlbauer; Robert D Stevens; Zehra Pamuklar; Jiegen Chen; Christopher B Newgard; Alfonso Torquati
Journal:  Ann Surg       Date:  2014-04       Impact factor: 12.969

8.  Adipose tissue metabolic and inflammatory responses to a mixed meal in lean, overweight and obese men.

Authors:  Rebecca L Travers; Alexandre C Motta; James A Betts; Dylan Thompson
Journal:  Eur J Nutr       Date:  2015-10-29       Impact factor: 5.614

9.  Association of a glucagon-like peptide-1 receptor gene variant with glucose response to a mixed meal.

Authors:  Mona Mashayekhi; Jessica R Wilson; Scott Jafarian-Kerman; Hui Nian; Chang Yu; Megan M Shuey; James M Luther; Nancy J Brown
Journal:  Diabetes Obes Metab       Date:  2020-10-22       Impact factor: 6.408

10.  Safety and efficacy of hydrothermal duodenal mucosal resurfacing in patients with type 2 diabetes: the randomised, double-blind, sham-controlled, multicentre REVITA-2 feasibility trial.

Authors:  Geltrude Mingrone; Annieke Cg van Baar; Jacques Devière; David Hopkins; Eduardo Moura; Cintia Cercato; Harith Rajagopalan; Juan Carlos Lopez-Talavera; Kelly White; Vijeta Bhambhani; Guido Costamagna; Rehan Haidry; Eduardo Grecco; Manoel Galvao Neto; Guruprasad Aithal; Alessandro Repici; Bu'Hussain Hayee; Amyn Haji; A John Morris; Raf Bisschops; Manil D Chouhan; Naomi S Sakai; Deepak L Bhatt; Arun J Sanyal; J J G H M Bergman
Journal:  Gut       Date:  2021-02-17       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.